Abstract
Although inflammation is presumed to contribute to colonic neoplasia in ulcerative colitis (UC), few studies have directly examined this relationship. Our aim was to determine whether severity of microscopic inflammation over time is an independent risk factor for neoplastic progression in UC. A cohort of patients with UC undergoing regular endoscopic surveillance for dysplasia was studied. Degree of inflammation at each biopsy site had been graded as part of routine clinical care using a highly reproducible histologic activity index. Progression to neoplasia was analyzed in proportional hazards models with inflammation summarized in 3 different ways and each included as a time-changing covariate: (1) mean inflammatory score (IS-mean), (2) binary inflammatory score (IS-bin), and (3) maximum inflammatory score (IS-max). Potential confounders were analyzed in univariate testing and, when significant, in a multivariable model. Of 418 patients who met inclusion criteria, 15 progressed to advanced neoplasia (high-grade dysplasia or colorectal cancer), and 65 progressed to any neoplasia (low-grade dysplasia, high-grade dysplasia, or colorectal cancer). Univariate analysis demonstrated significant relationships between histologic inflammation over time and progression to advanced neoplasia (hazard ration (HR), 3.0; 95% CI: 1.4-6.3 for IS-mean; HR, 3.4; 95% CI: 1.1-10.4 for IS-bin; and HR, 2.2; 95% CI: 1.2-4.2 for IS-max). This association was maintained in multivariable proportional hazards analysis. The severity of microscopic inflammation over time is an independent risk factor for developing advanced colorectal neoplasia among patients with long-standing UC.
MeSH Terms
Adult
Cohort Studies
Colitis, Ulcerative/complications,pathology
Colonoscopy
Colorectal Neoplasms/etiology,pathology
Databases as Topic
Disease Progression
Female
Follow-Up Studies
Humans
Inflammation/complications,pathology
Male
Proportional Hazards Models
Risk Assessment
Risk Factors
Severity of Illness Index
Time Factors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gupta Roopali Bansal
Department of Medicine, The University of Texas Southwestern, Dallas, Texas, USA.
Harpaz Noam
Itzkowitz Steven
Hossain Sabera
Matula Sierra
Kornbluth Asher
Bodian Carol
Ullman Thomas
References (28)
28 references, click to expand
-
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
Gastroenterology. 2006 Jun;130(7):1941-9
PMID: 16762617
-
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
Lancet. 1994 Jan 8;343(8889):71-4
PMID: 7903776
-
Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis.
Am J Gastroenterol. 1998 Jun;93(6):872-80
PMID: 9647011
-
Patients with low-grade dysplasia should be advised to undergo colectomy.
Inflamm Bowel Dis. 2003 Jul;9(4):267-9; discussion 273-5
PMID: 12902850
-
How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.
Gastrointest Endosc. 2000 Feb;51(2):123-8
PMID: 10650251
-
Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.
Inflamm Bowel Dis. 2005 Mar;11(3):314-21
PMID: 15735438
-
Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.
Hum Pathol. 1989 Oct;20(10):1008-14
PMID: 2793156
-
Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.
Inflamm Bowel Dis. 2003 Nov;9(6):351-5
PMID: 14671483
-
Is histology useful for the assessment of the efficacy of immunosuppressive agents in IBD and if so, how should it be applied ?
Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):285-9
PMID: 15587337
-
Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis.
J Pathol. 2001 Jun;194(2):152-7
PMID: 11400142
-
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.
Gastroenterology. 2004 Feb;126(2):451-9
PMID: 14762782
-
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.
Hum Pathol. 1983 Nov;14(11):931-68
PMID: 6629368
-
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.
Gastroenterology. 1994 Oct;107(4):934-44
PMID: 7926483
-
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps.
Gastroenterology. 1999 Dec;117(6):1295-300
PMID: 10579970
-
Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia.
Gastroenterology. 1992 Aug;103(2):431-8
PMID: 1634062
-
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G7-17
PMID: 15194558
-
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
Gastroenterology. 2003 Nov;125(5):1311-9
PMID: 14598247
-
Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.
Gastroenterology. 1994 Jul;107(1):117-20
PMID: 7912678
-
Ulcerative colitis and colorectal cancer. A population-based study.
N Engl J Med. 1990 Nov 1;323(18):1228-33
PMID: 2215606
-
The risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut. 2001 Apr;48(4):526-35
PMID: 11247898
-
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
Gastroenterology. 2004 May;126(6):1634-48
PMID: 15168373
-
The fate of low grade dysplasia in ulcerative colitis.
Am J Gastroenterol. 2002 Apr;97(4):922-7
PMID: 12008669
-
Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.
Am J Gastroenterol. 1995 Dec;90(12):2106-14
PMID: 8540497
-
Failure of colonoscopic surveillance in ulcerative colitis.
Gut. 1993 Aug;34(8):1075-80
PMID: 8174957
-
Assessing disease activity and disease activity indices for inflammatory bowel disease.
Curr Gastroenterol Rep. 2002 Dec;4(6):490-6
PMID: 12441039
-
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis.
Gut. 2000 Sep;47(3):404-9
PMID: 10940279
-
Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis.
Gastroenterology. 1999 Dec;117(6):1288-94; discussion 1488-91
PMID: 10579969
-
Colorectal cancer prevention in ulcerative colitis: a case-control study.
Aliment Pharmacol Ther. 2000 Feb;14(2):145-53
PMID: 10651654